Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Amortization of Deferred Charges (2023 - 2025)

Historic Amortization of Deferred Charges for Q32 Bio (QTTB) over the last 3 years, with Q3 2025 value amounting to $46000.0.

  • Q32 Bio's Amortization of Deferred Charges fell 800.0% to $46000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $192000.0, marking a year-over-year increase of 971.43%. This contributed to the annual value of $194000.0 for FY2024, which is 12298.85% up from last year.
  • Latest data reveals that Q32 Bio reported Amortization of Deferred Charges of $46000.0 as of Q3 2025, which was down 800.0% from $49000.0 recorded in Q2 2025.
  • Q32 Bio's 5-year Amortization of Deferred Charges high stood at $66000.0 for Q2 2024, and its period low was $7000.0 during Q3 2023.
  • Its 3-year average for Amortization of Deferred Charges is $38545.5, with a median of $46000.0 in 2025.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first skyrocketed by 61428.57% in 2024, then tumbled by 2575.76% in 2025.
  • Over the past 3 years, Q32 Bio's Amortization of Deferred Charges (Quarter) stood at $30000.0 in 2023, then skyrocketed by 63.33% to $49000.0 in 2024, then decreased by 6.12% to $46000.0 in 2025.
  • Its last three reported values are $46000.0 in Q3 2025, $49000.0 for Q2 2025, and $48000.0 during Q1 2025.